Inhibition of primary colon carcinoma growth and liver metastasis by the A3 adenosine receptor agonist CF101 (Q38602671)

From Wikidata

Jump to navigation Jump to search

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

scientific article published on October 20, 2003

Language	Label	Description	Also known as
English	Inhibition of primary colon carcinoma growth and liver metastasis by the A3 adenosine receptor agonist CF101	scientific article published on October 20, 2003

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

4 September 2017

Inhibition of primary colon carcinoma growth and liver metastasis by the A3 adenosine receptor agonist CF101 (English)

1 reference

10.1038/SJ.BJC.6601315

https://api.crossref.org/works/10.1038/SJ.BJC.6601315

21 March 2024

colon carcinoma

1 reference

based on heuristic

inferred from title

liver metastasis

1 reference

based on heuristic

inferred from title

1 reference

10.1038/SJ.BJC.6601315

https://api.crossref.org/works/10.1038/SJ.BJC.6601315

21 March 2024

9

object named as

P Fishman

1 reference

Europe PubMed Central

PMC publication ID

4 September 2017

author name string

G. Ohana

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14562031

21 March 2024

S. Bar-Yehuda

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14562031

21 March 2024

A. Arich

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14562031

21 March 2024

L. Madi

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14562031

21 March 2024

Z. Dreznick

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14562031

21 March 2024

L. Rath-Wolfson

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14562031

21 March 2024

D. Silberman

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14562031

21 March 2024

G. Slosman

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14562031

21 March 2024

language of work or name

0 references

publication date

1 October 2003

1 reference

Europe PubMed Central

PMC publication ID

4 September 2017

20 October 2003

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14562031

21 March 2024

full work available at URL

https://www.nature.com/articles/6601315.pdf

Portable Document Format

online access status

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14562031

21 March 2024

https://europepmc.org/articles/PMC2394357

online access status

content deliverer

Europe PubMed Central

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14562031

21 March 2024

https://europepmc.org/articles/PMC2394357?pdf=render

Portable Document Format

online access status

content deliverer

Europe PubMed Central

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14562031

21 March 2024

http://www.nature.com/articles/6601315.pdf

Portable Document Format

1 reference

10.1038/SJ.BJC.6601315

https://api.crossref.org/works/10.1038/SJ.BJC.6601315

21 March 2024

http://www.nature.com/articles/6601315

1 reference

10.1038/SJ.BJC.6601315

https://api.crossref.org/works/10.1038/SJ.BJC.6601315

21 March 2024

British Journal of Cancer

1 reference

Europe PubMed Central

PMC publication ID

4 September 2017

89

1 reference

Europe PubMed Central

PMC publication ID

4 September 2017

8

1 reference

Europe PubMed Central

PMC publication ID

4 September 2017

1552-1558

1 reference

Europe PubMed Central

PMC publication ID

4 September 2017

The biology of natural killer cells in cancer, infection, and pregnancy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2394357

6 September 2017

Resistance of muscle to tumor metastases: a role for a3 adenosine receptor agonists

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2394357

6 September 2017

Adenosine A3 receptor stimulation and cerebral ischemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2394357

6 September 2017

Structure and function of A1 adenosine receptors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2394357

6 September 2017

Adenosine acts as an inhibitor of lymphoma cell growth: a major role for the A3 adenosine receptor

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2394357

27 September 2017

Oral administration of muscle derived small molecules inhibits tumor spread while promoting normal cell growth in mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2394357

27 September 2017

The regulation and biological activity of interleukin 12.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2394357

27 September 2017

Adenosine A3 receptor agonists inhibit murine macrophage tumor necrosis factor-alpha production in vitro and in vivo.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2394357

27 September 2017

Interleukin-12 and its role in the generation of TH1 cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2394357

27 September 2017

Stages of intestinal carcinogenesis and their control by host NK cells. Implications to prevention and therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2394357

23 June 2018

Muscle cells produce a low molecular weight factor with anti-cancer activity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2394357

23 June 2018

Targeting the A3 adenosine receptor for cancer therapy: inhibition of prostate carcinoma cell growth by A3AR agonist

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2394357

31 August 2018

Agonists to the A3 adenosine receptor induce G-CSF production via NF-kappaB activation: a new class of myeloprotective agents

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2394357

31 August 2018

Evidence for involvement of Wnt signaling pathway in IB-MECA mediated suppression of melanoma cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2394357

31 August 2018

The A3 adenosine receptor as a new target for cancer therapy and chemoprotection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2394357

31 August 2018

Ligand-activation of the adenosine A2a receptors inhibits IL-12 production by human monocytes.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2394357

31 August 2018

Adenosine and other low molecular weight factors released by muscle cells inhibit tumor cell growth.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2394357

31 August 2018

A3-adenosine receptors: design of selective ligands and therapeutic prospects

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6601315

21 January 2018

Adenosine acts as a chemoprotective agent by stimulating G-CSF production: a role for A1 and A3 adenosine receptors

1 reference

https://pubmed.ncbi.nlm.nih.gov/14562031

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The anti-tumor activity of IL-12: mechanisms of innate immunity that are model and dose dependent

1 reference

https://pubmed.ncbi.nlm.nih.gov/14562031

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interleukin-3 and granulocyte colony-stimulating factor as survival factors in murine hemopoietic stem cells in vitro

1 reference

https://pubmed.ncbi.nlm.nih.gov/14562031

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adenosine receptors and beyond: molecular mechanisms of physiological regulation

1 reference

https://pubmed.ncbi.nlm.nih.gov/14562031

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Synergistic factors for stem cell proliferation: further studies of the target stem cells and the mechanism of stimulation by interleukin-1, interleukin-6, and granulocyte colony-stimulating factor

1 reference

https://pubmed.ncbi.nlm.nih.gov/14562031

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Modulation of human natural killer cell activity by pharmacological mediators

1 reference

https://pubmed.ncbi.nlm.nih.gov/14562031

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Synergistic effect of granulocyte colony-stimulating factor and drugs elevating extracellular adenosine on neutrophil production in mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/14562031

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evidence that the adenosine A3 receptor may mediate the protection afforded by preconditioning in the isolated rabbit heart

1 reference

https://pubmed.ncbi.nlm.nih.gov/14562031

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Elevation of extracellular adenosine induces radioprotective effects in mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/14562031

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

United Kingdom Co-ordinating Committee on Cancer Research (UKCCCR) Guidelines for the Welfare of Animals in Experimental Neoplasia (Second Edition)

1 reference

https://pubmed.ncbi.nlm.nih.gov/14562031

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Granulocyte colony-stimulating factor and drugs elevating extracellular adenosine synergize to enhance haematopoietic reconstitution in irradiated mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/14562031

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An agonist of adenosine A3 receptors decreases interleukin-12 and interferon-gamma production and prevents lethality in endotoxemic mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/14562031

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cellular and Molecular Biology

5

43

345

author name string

TL Bowlin

publication date

1997

1 reference

10.1038/SJ.BJC.6601315

https://api.crossref.org/works/10.1038/SJ.BJC.6601315

21 March 2024

Clinical Research

27

38

10

author name string

G Stiles

publication date

1990

1 reference

10.1038/SJ.BJC.6601315

https://api.crossref.org/works/10.1038/SJ.BJC.6601315

21 March 2024

British Journal of Cancer

30

77

1

author name string

P Workman

publication date

1998

1 reference

10.1038/SJ.BJC.6601315

https://api.crossref.org/works/10.1038/SJ.BJC.6601315

21 March 2024

Identifiers

10.1038/SJ.BJC.6601315

1 reference

Europe PubMed Central

PMC publication ID

4 September 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

4 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

4 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38602671&oldid=2201868268"